Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Arbea, Leire ^a   Ramos, Luis I ^a   Martínez Monge, Rafael ^a   Moreno, Marta ^a   Aristu, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3D CONFORMAL RADIOTHERAPY; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LOCALLY ADVANCED RECTAL CANCER; RECTUM CANCER; TREATMENT PLANNING; TUMOR VOLUME; BLADDER; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; RADIATION EXPOSURE; RADIOMETRY; RECTUM; RECTUM TUMOR;

HUMANS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RECTUM; URINARY BLADDER;

EID: 77949400747     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-17     Document Type: Article

References (38)

1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351(17):1731-1740. 10.1056/NEJMoa040694, 15496622.
2. Sauer R, Fietkau R, Wittekind C, Rodel C, Martus P, Hohenberger W, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis 2003, 5(5):406-415. 10.1046/j.1463-1318.2003.00509.x, 12925071.
3. Bosset JF, Magnin V, Maingon P, Mantion G, Pelissier EP, Mercier M, et al. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000, 46(2):323-327. 10.1016/S0360-3016(99)00411-3, 10661338.
4. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004, 40(2):219-224. 10.1016/j.ejca.2003.09.032, 14728936.
5. Grann A, Minsky BD, Cohen AM, Saltz L, Guillem JG, Paty PB, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997, 40(5):515-522. 10.1007/BF02055370, 9152176.
6. Bosset JF, Meneveau N, Pavy JJ. [Late intestinal complications of adjuvant radiotherapy of rectal cancers]. Cancer Radiother 1997, 1(6):770-774.
7. Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006, 66(2):505-513.
8. Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002, 52(1):176-183.
9. Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 2003, 91(1):39-45. 10.1016/S0090-8258(03)00461-X, 14529660.
10. Luxton G, Hancock SL, Boyer AL. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2004, 59(1):267-284.
11. Duthoy W, De Gersem W, Vergote K, Boterberg T, Derie C, Smeets P, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 2004, 60(3):794-806.
12. Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006, 65(3):907-916.
13. International Commission on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy ICRU Report 62. 1999, Bethesda, MD: International Commission on Radiation Units and Measurements, 2010, International Commission on Radiation Units and Measurements.
14. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974, 34(4):1278-1292. 10.1002/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F, 4424091.
15. Ahnesjo A, Saxner M, Trepp A. A pencil beam model for photon dose calculation. Med Phys 1992, 19(2):263-273. 10.1118/1.596856, 1584117.
16. Aristu J, Azcona JD, Moreno M, Martinez-Monge R. Rectal Cancer Case study. INTENSITY MODULATED RADIATION THERAPY. A clinical perspective 2005, Hamilton, Ontario, Mundt A, Roeske JC.
17. Aristu JJ, Arbea L, Rodriguez J, Hernandez-Lizoain JL, Sola JJ, Moreno M, et al. Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2008, 71(3):748-755.
18. Bortfeld T, Schlegel W, Rhein B. Decomposition of pencil beam kernels for fast dose calculations in three-dimensional treatment planning. Med Phys 1993, 20(2 Pt 1):311-318. 10.1118/1.597070, 8497215.
19. Yoon M, Park SY, Shin D, Lee SB, Pyo HR, Kim DY, et al. A new homogeneity index based on statistical analysis of the dose-volume histogram. J Appl Clin Med Phys 2007, 8(2):9-17.
20. Knoos T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 1998, 42(5):1169-1176.
21. Hoogeman MS, van Herk M, de Bois J, Lebesque JV. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 2005, 74(2):177-185. 10.1016/j.radonc.2004.12.010, 15734206.
22. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995, 33(5):1109-1119.
23. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003, 69(3):291-304. 10.1016/S0167-8140(03)00246-9, 14644489.
24. Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995, 33(5):1321-1329.
25. Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, et al. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006, 80(3):363-370. 10.1016/j.radonc.2006.08.007, 16959344.
26. Nuyttens JJ, Robertson JM, Yan D, Martinez A. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 2002, 53(2):497-503.
27. Myerson RJ, Genovesi D, Lockett MA, Birnbaum E, Fleshman J, Fry R, et al. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment. Int J Radiat Oncol Biol Phys 1999, 43(3):537-543.
28. Nuyttens JJ, Robertson JM, Yan D, Martinez A. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother 2004, 8(5):297-304.
29. Goitein M, Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Int J Radiat Oncol Biol Phys 1996, 36(2):519-522.
30. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984, 23(5):379-391. 10.3109/02841868409136037, 6095609.
31. Niemierko A, Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 1993, 29(2):140-147. 10.1016/0167-8140(93)90239-5, 8310139.
32. Howell RM, Hertel NE, Wang Z, Hutchinson J, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 2006, 33(2):360-368. 10.1118/1.2140119, 16532941.
33. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62(4):1204-1216.
34. Mutic S, Low DA. Whole-body dose from tomotherapy delivery. Int J Radiat Oncol Biol Phys 1998, 42(1):229-232.
35. Followill D, Geis P, Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997, 38(3):667-672.
36. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62(4):1195-1203.
37. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56(1):83-88.
38. Dorr W, Herrmann T. Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume. J Radiol Prot 2002, 22(3A):A117-A121. 10.1088/0952-4746/22/3A/321, 12400959.